Confluent, Inc. (CFLT)

Longboard Pharmaceuticals Statistics

Total Valuation

Confluent has a market cap or net worth of $5.93 billion. The enterprise value is $5.10 billion.

Market Cap	5.93B
Enterprise Value	5.10B

Important Dates

The last earnings date was Wednesday, July 30, 2025, after market close.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Confluent has 344.74 million shares outstanding.

Current Share Class	291.93M
Shares Outstanding	344.74M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.09%
Owned by Institutions (%)	79.12%
Float	275.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	43.64
PS Ratio	5.37
Forward PS	4.62
PB Ratio	5.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.35

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	3,060
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.25% in the last 52 weeks. The beta is 0.96, so Confluent's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-31.25%
50-Day Moving Average	24.19
200-Day Moving Average	26.21
Relative Strength Index (RSI)	21.08
Average Volume (20 Days)	9,016,787

Short Selling Information

The latest short interest is 22.34 million, so 6.48% of the outstanding shares have been sold short.

Short Interest	22.34M
Short Previous Month	19.86M
Short % of Shares Out	6.48%
Short % of Float	8.10%
Short Ratio (days to cover)	4.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	-331.01M
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Confluent does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

The average price target for Confluent is $29.30, which is 70.35% higher than the current price. The consensus rating is "Buy".

Price Target	$29.30
Price Target Difference	70.35%
Analyst Consensus	Buy
Analyst Count	30
Revenue Growth Forecast (5Y)	18.04%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a